Ms. Angela Cechetto reports

GREY WOLF ANIMAL HEALTH APPOINTS A VICE PRESIDENT, SALES & MARKETING TO ADVANCE COMMERCIAL STRATEGY

Grey Wolf Animal Health Corp. has appointed Susan Bodner as vice-president, sales and marketing, effective April 13, 2026.

Ms. Bodner brings over 15 years of experience in sales and marketing with a strong record in commercial transformation, execution of data-driven strategies, and building collaborative teams across customer service, key account management, sales and marketing. Ms. Bodner has held senior positions within the medical device industry, where she has successfully led commercial organizations to drive growth.

In this role, Ms. Bodner will be responsible for leading Grey Wolf's marketing and sales activities, including developing a collaborative commercial strategy for both the pharmacy and animal health business units, strengthening customer relationships, and supporting the long-term growth of Grey Wolf's products and services.

"Ms. Bodner's expertise in sales and marketing and proven ability to successfully build and execute commercial strategies across diverse areas make her an excellent addition to our leadership team," said Angela Cechetto, chief executive officer of Grey Wolf. "As we continue to grow across human and animal health, Ms. Bodner will play a critical role in developing a strategy that will focus on maximizing synergies between our compounding pharmacy business in both human and animal health and our animal health business to grow sales and market share. We are pleased to welcome her to the team."

"I am excited to join Grey Wolf at such an important stage of its growth," said Ms. Bodner. "The company is well positioned within both the pharmacy and animal health markets, and I look forward to building a strong commercial foundation to support future growth and product launches."

About Grey Wolf Animal Health Corp.

Grey Wolf Animal Health, headquartered in Toronto, Canada, is a diversified health company founded by a veterinarian to bring to market a broad portfolio of products that meet the unmet needs of veterinarians, physicians and patients. The company's strategy is to in-license, acquire or compound prescription and non-prescription products for commercialization in the animal and human health market in Canada.

We seek Safe Harbor.